|
Deep Knowledge Ventures (DKV) is a Hong Kong-based (a Special Administrative Region of the People's Republic of China) venture capital fund management company focusing on health biotechnology companies, artificial intelligence, personalized medicine, big data analytics systems and Financial Technology. Deep Knowledge Ventures was established by Dmitry Kaminskiy and other partners in early 2014. The Hong Kong- based fund has particular interests in human longevity and artificial intelligence.DKV is developing therapies for aging-associated diseases, regenerative medicine and oncology investments at an early-stage.〔(DEEP KNOWLEDGE VENTURES )〕 Deep Knowledge Ventures gained attention in 2014 when it announced the appointment of an Artificial Intelligence “VITAL”, the Validating Investment Tool for Advancing Life Sciences, to its board of directors. () ==Investing areas== * biotechnology - with an emphasis on “personalized” medicine (preventive medicine, anti-aging, and reversal of aging) * aerospace - as a realistic possibility for commercial space exploration and the expansion of human potential * AI&Big Data hybrid - especially in the field of personalized medicine, financial analysis and risk analysis * high tech platforms * projects, related to exponential technologies 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Deep Knowledge Ventures」の詳細全文を読む スポンサード リンク
|